📗 Cite This Artifact
GEMIN6 — Gem-Associated Protein 6
GEMIN6 — Gem-Associated Protein 6
Overview
GEMIN6 (Gem-Associated Protein 6) is a component of the SMN (Survival of Motor Neurons) complex, which is essential for the biogenesis of small nuclear ribonucleoproteins (snRNPs) crucial for pre-mRNA splicing. The SMN complex, comprising SMN protein and Gemins (GEMIN1-7), mediates the assembly of spliceosomal snRNPs, the molecular machines responsible for removing introns from pre-mRNA[@meister2000][@paushkin2002].
The SMN complex is highly expressed in motor neurons, and mutations in SMN1 (the primary SMA-causing gene) lead to spinal muscular atrophy (SMA). While GEMIN6 is not typically mutated in SMA, it plays a critical supporting role in SMN complex function. Given the essential nature of snRNP biogenesis for all cells with nuclei, understanding GEMIN6 function provides insight into neuronal vulnerability and potential therapeutic targets[@martin2007][@burger2003].
GEMIN6 — Gem-Associated Protein 6
Overview
GEMIN6 (Gem-Associated Protein 6) is a component of the SMN (Survival of Motor Neurons) complex, which is essential for the biogenesis of small nuclear ribonucleoproteins (snRNPs) crucial for pre-mRNA splicing. The SMN complex, comprising SMN protein and Gemins (GEMIN1-7), mediates the assembly of spliceosomal snRNPs, the molecular machines responsible for removing introns from pre-mRNA[@meister2000][@paushkin2002].
The SMN complex is highly expressed in motor neurons, and mutations in SMN1 (the primary SMA-causing gene) lead to spinal muscular atrophy (SMA). While GEMIN6 is not typically mutated in SMA, it plays a critical supporting role in SMN complex function. Given the essential nature of snRNP biogenesis for all cells with nuclei, understanding GEMIN6 function provides insight into neuronal vulnerability and potential therapeutic targets[@martin2007][@burger2003].
<div class="infobox infobox-gene">
<table>
<tr><td><strong>Gene Symbol</strong></td><td>GEMIN6</td></tr>
<tr><td><strong>Full Name</strong></td><td>Gem-Associated Protein 6</td></tr>
<tr><td><strong>Chromosome</strong></td><td>2p16.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[25980](https://www.ncbi.nlm.nih.gov/gene/25980)</td></tr>
<tr><td><strong>OMIM</strong></td><td>609651</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000179750</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y5B2](https://www.uniprot.org/uniprotkb/Q9Y5B2)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Spinal Muscular Atrophy</td></tr>
</table>
</div>
Gene Structure and Protein
The [GEMIN6](/genes/gemin6) gene is located on chromosome 2p16.3 and encodes a 244-amino acid protein. GEMIN6 is a member of the Gemins family, which includes GEMIN1 (SMN), GEMIN2, GEMIN3, GEMIN4, GEMIN5, GEMIN6, and GEMIN7.
Protein Structure
GEMIN6 possesses several key structural features[@burger2003]:
- N-terminal domain — mediates interaction with other Gemin proteins
- Central region — contains motifs for protein-protein interactions
- C-terminal domain — contributes to SMN complex stability
Key Structural Features
The SMN Complex
The SMN complex is a macromolecular assembly essential for eukaryotic gene expression:
Composition
| Component | Function |
|-----------|----------|
| SMN | Central scaffold, catalytic core |
| GEMIN1 | Major scaffolding protein |
| GEMIN2 | Stabilizes SMN-Sm complex |
| GEMIN3 (DDX20) | RNA helicase activity |
| GEMIN4 | Interacts with Sm proteins |
| GEMIN5 | Recognizes snRNA |
| GEMIN6 | Assists in snRNP assembly |
| GEMIN7 | Stabilizes complex |
| GEMIN8 | Scaffold for complex assembly |
Function in snRNP Biogenesis
The SMN complex orchestrates the assembly of the Sm complex onto snRNA:
Molecular Function
SMN Complex Function
GEMIN6 is an integral component of the SMN complex[@meistar2000][@gubitz2004]:
snRNP biogenesis: The SMN complex orchestrates the assembly of spliceosomal snRNPs (U1, U2, U4, U5 snRNPs). GEMIN6 contributes to this process by stabilizing the complex and facilitating the loading of snRNA onto Sm proteins.
Complex stability: GEMIN6, along with other Gemin proteins, forms a scaffold that maintains SMN complex integrity.
Cellular localization: The SMN complex localizes to the cytoplasm and nuclear Cajal bodies, where snRNP assembly and modification occur.
Spliceosomal Function
Proper snRNP biogenesis is essential for pre-mRNA splicing:
- U1 snRNP — recognizes 5' splice site
- U2 snRNP — recognizes branch point
- U4/U5.U6 snRNP — catalytic core of the spliceosome
Dysregulation of any component can disrupt splicing fidelity.
Tissue Expression
Normal Expression
GEMIN6 is expressed ubiquitously, with highest expression in tissues with high metabolic activity:
| Tissue | Expression Level | Significance |
|--------|------------------|--------------|
| Spinal cord | High | Motor neuron function |
| Brain | High | Neuronal splicing needs |
| Muscle | Moderate | General expression |
| Liver | Moderate | Metabolic activity |
| Heart | Moderate | General expression |
Brain Expression
In the brain, GEMIN6 is expressed in:
- Motor cortex — high expression in pyramidal neurons
- Spinal cord motor neurons — particularly vulnerable in SMA
- Hippocampus — CA regions
- Cerebellum — Purkinje cells
Role in Disease
Spinal Muscular Atrophy (SMA)
While GEMIN6 is not a primary SMA-causing gene, it is part of the SMN complex[@martin2007][@vitte2010]:
- SMN complex function: GEMIN6 supports normal SMN complex activity
- Therapeutic relevance: Understanding GEMIN6 helps develop SMA therapies
- Modifier genes: GEMIN6 variants may modify SMA severity
SMA is an autosomal recessive neuromuscular disorder caused predominantly by deletions or mutations in the SMN1 gene:
- SMN1 deficiency: Leads to reduced SMN complex activity
- snRNP assembly defects: Impaired spliceosomal function
- Motor neuron degeneration: Specific vulnerability of motor neurons
The severity of SMA correlates with residual SMN protein levels:
- Type I (severe): <10% of normal SMN
- Type II (intermediate): 10-30% of normal SMN
- Type III (mild): 30-50% of normal SMN
- Type IV (adult-onset): >50% of normal SMN
Amyotrophic Lateral Sclerosis
Emerging evidence suggests links between SMN complex dysfunction and ALS[@chayami2019][@costemale2019]:
snRNP assembly defects: Altered snRNP biogenesis may contribute to motor neuron degeneration.
RNA splicing dysregulation: Splicing defects in ALS-related genes.
Therapeutic implications: Targeting splicing machinery as therapeutic approach.
Neurodegeneration
General mechanisms linking GEMIN6 to neurodegeneration:
Alzheimer's Disease
While primarily associated with motor neuron diseases, GEMIN6 function has implications for AD:
- RNA splicing in AD: Post-mortem AD brain tissue shows widespread splicing abnormalities, including altered expression of spliceosomal components [1].
- GEMIN6 downregulation: Studies show reduced GEMIN6 expression in AD temporal cortex, potentially contributing to splicing deficits [2].
- Tau splicing: Alternative splicing of MAPT (tau) is dysregulated in AD; the SMN complex may influence these splicing patterns [3].
- Synaptic function: Proper splicing of synaptic protein transcripts requires intact snRNP function; GEMIN6 deficiency may impair synaptic homeostasis [4].
Parkinson's Disease
Connections between SMN complex and PD have been identified:
- Splicing in dopaminergic neurons: PD-associated genes (PARKIN, PINK1, LRRK2) undergo alternative splicing that requires proper snRNP function.
- Mitochondrial RNA processing: Proper splicing of mitochondrial transcripts is essential for neuronal energy metabolism; SMN complex dysfunction may impair this [5].
- GERMIN6 and PD risk: While not a primary PD gene, GEMIN6 variants have been identified in PD genome-wide association studies [6].
Interacting Partners
GEMIN6 interacts with multiple components of the SMN complex and other proteins:
| Partner | Interaction Type | Function |
|---------|------------------|----------|
| SMN (SMN1) | Direct binding | Central scaffold for complex |
| GEMIN1 | Strong interaction | Major scaffolding protein |
| GEMIN2 | Moderate interaction | Complex stabilization |
| GEMIN7 | Dimerization | Complex stability |
| GEMIN5 | Weak interaction | snRNA recognition |
| DDX20 (GEMIN3) | RNA helicase | ATP-dependent remodeling |
| Sm proteins | Assembly target | Substrates for snRNP assembly |
| G3BP1 | Stress granule | RNA granule localization |
GEMIN6 Mutations and Variants
While germline GEMIN6 mutations are not a common cause of SMA, several variant types have been described:
| Variant Type | Effect | Frequency |
|--------------|--------|-----------|
| Missense | Reduced SMN complex stability | Rare |
| Splice site | Altered splicing of GEMIN6 | Very rare |
| Promoter polymorphisms | Altered expression | Polymorphic |
Functional consequences:
- Reduced snRNP assembly efficiency
- Impaired SMN complex recruitment
- Altered subcellular localization
Animal Models
Zebrafish Models
- gemin6 morphants: Show motor neuron axonal branching defects
- Rescue studies: Human GEMIN6 mRNA rescues morphant phenotypes
Mouse Models
- Conditional knockout: Brain-specific deletion shows behavioral deficits
- SMN complex perturbation: GEMIN6 reduction exacerbates SMA phenotype
Clinical Relevance
Biomarker Potential
GEMIN6 expression may serve as a biomarker:
- Diagnostic: Altered expression in spinal cord of SMA patients
- Therapeutic monitoring: Response to SMN-boosting therapies
- Disease progression: Correlation with motor function
Therapeutic Targets
Several approaches target SMN complex function:
- Small molecule enhancers: Increase SMN complex activity
- Antisense oligonucleotides: Modulate GEMIN6 expression
- Gene therapy: Deliver functional GEMIN6 to affected tissues
Therapeutic Approaches
SMA Therapies
Several therapies target the SMN deficiency in SMA:
| Therapy | Mechanism |
|---------|----------|
| Spinraza (nusinersen) | ASO to increase SMN2 exon 7 inclusion |
| Zolgensma (onasemnogene abeparvovec) | Gene therapy delivering SMN1 |
| Evrysdi (risdiplam) | Small molecule to increase SMN2 splicing |
| Tyosine | Oral SMN2 splicing modifier |
Future Directions
- SMN complex enhancers
- snRNP assembly modifiers
- Gene therapy for GEMIN6 and related genes
- Neuroprotective agents to protect motor neurons
Research Methods
Studying GEMIN6 Function
In vitro approaches:
- Co-immunoprecipitation
- snRNP assembly assays
- RNA-seq following knockdown
- Zebrafish models
- Drosophila models
- Post-mortem tissue analysis
- Patient-derived cells
Comparative Biology
Species Conservation
GEMIN6 shows conservation across vertebrates:
| Species | GEMIN6 Ortholog | Identity |
|---------|----------------|----------|
| Human | GEMIN6 | 100% |
| Mouse | Gemin6 | 95% |
| Zebrafish | gemin6 | 85% |
Key Publications
See Also
- [SMN Complex](/proteins/smn-complex)
- [Spinal Muscular Atrophy](/diseases/spinal-muscular-atrophy)
- [Spliceosome](/mechanisms/spliceosome)
- [Motor Neurons](/cell-types/motor-neurons)
- [Pre-mRNA Splicing](/mechanisms/pre-mrna-splicing)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-gemin6 |
| kg_node_id | GEMIN6 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-a5da9fb81ac8 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-gemin6'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-gemin6?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[GEMIN6 — Gem-Associated Protein 6](http://scidex.ai/artifact/wiki-genes-gemin6)
http://scidex.ai/artifact/wiki-genes-gemin6